Cite
Integrative Assessment of Pretreatment Inflammation-, Nutrition-, and Muscle-Based Prognostic Markers in Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy.
MLA
Miyake, Makito, et al. “Integrative Assessment of Pretreatment Inflammation-, Nutrition-, and Muscle-Based Prognostic Markers in Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy.” Oncology, vol. 93, no. 4, Sept. 2017, pp. 259–69. EBSCOhost, https://doi.org/10.1159/000477405.
APA
Miyake, M., Morizawa, Y., Hori, S., Marugami, N., Iida, K., Ohnishi, K., Gotoh, D., Tatsumi, Y., Nakai, Y., Inoue, T., anai, S., Torimoto, K., aoki, K., Tanaka, N., Shimada, K., Konishi, N., & Fujimoto, K. (2017). Integrative Assessment of Pretreatment Inflammation-, Nutrition-, and Muscle-Based Prognostic Markers in Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy. Oncology, 93(4), 259–269. https://doi.org/10.1159/000477405
Chicago
Miyake, Makito, Yosuke Morizawa, Shunta Hori, Nagaaki Marugami, Kota Iida, Kenta Ohnishi, Daisuke Gotoh, et al. 2017. “Integrative Assessment of Pretreatment Inflammation-, Nutrition-, and Muscle-Based Prognostic Markers in Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy.” Oncology 93 (4): 259–69. doi:10.1159/000477405.